Tango Therapeutics
TNGX
#3295
Rank
โ‚ฌ4.13 B
Marketcap
25,42ย โ‚ฌ
Share price
5.37%
Change (1 day)
340.81%
Change (1 year)

Revenue for Tango Therapeutics (TNGX)

Revenue in 2026 (TTM): โ‚ฌ48.55 Million

According to Tango Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚ฌ49.92 Million. In 2025 the company made a revenue of โ‚ฌ53.1 Million an increase over the revenue in the year 2024 that were of โ‚ฌ40.42 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Tango Therapeutics from 2021 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ48.55 M-8.58%
2025 โ‚ฌ53.1 M31.36%
2024 โ‚ฌ40.42 M22.35%
2023 โ‚ฌ33.04 M42.57%
2022 โ‚ฌ23.17 M-29.14%
2021 โ‚ฌ32.7 M